-+ 0.00%
-+ 0.00%
-+ 0.00%

*Revolution Medicines: Alan Sandler, Chief Development Officer, to Continue to Oversee the Company's Development Department; Jan Smith, Chief Scientific Officer, to Oversee Research Activities >RVMD

Dow Jones·06/22/2026 12:02:00

Please log in to view news